We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ACW market cap is 60.5M. The company's latest EPS is AUD -0.0056 and P/E is -5.36.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 3.52M | 1.98M | 3.64M | 4.89M | 9.93M |
| Operating Income | -5.4M | -3.92M | -9.53M | -10.99M | -13.26M |
| Net Income | -5.33M | -3.92M | -9.5M | -10.75M | -13.04M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 11.94M | 18.38M | 23.31M | 15.21M | 21.31M |
| Total Liabilities | 1.05M | 920k | 1.57M | 1.8M | 1.62M |
| Total Equity | 10.89M | 17.46M | 21.74M | 13.41M | 19.7M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -2.86M | -1.72M | -9.52M | -8.7M | -16.95M |
| Investing | -23k | -6k | -3k | -37k | -8k |
| Financing | 282k | 10.11M | 12.42M | 825k | 17.95M |
| Market Cap | 60.5M |
| Price to Earnings Ratio | -5.36 |
| Price to Sales Ratio | 6.98 |
| Price to Cash Ratio | 7.32 |
| Price to Book Ratio | 3.54 |
| Dividend Yield | - |
| Shares Outstanding | 2.33B |
| Average Volume (1 week) | 4.73M |
| Average Volume (1 Month) | 3.89M |
| 52 Week Change | 4.00% |
| 52 Week High | 0.099 |
| 52 Week Low | 0.02 |
| Spread (Intraday) | 0 (7.69%) |
| Company Name | Actinogen Medical Limited |
| Address |
level 9 sydney, new south wales 2000 |
| Website | https://www.actinogen.com.au |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
